Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. en.wikipedia.org › wiki › Lou_GerstnerLou Gerstner - Wikipedia

    Louis Vincent Gerstner Jr. (born March 1, 1942) is an American businessman, best known for his tenure as chairman of the board and chief executive officer of IBM from April 1993 until 2002, when he retired as CEO in March and chairman in December.

  2. Louis V. Gerstner Jr. served as chief executive officer and chairman of the board of IBM Corporation from April 1993 to March 2002 and chairman until his retirement in December 2002.

  3. Louis V. Gerstner, Jr. served as chief executive officer and chairman of the board of IBM Corporation from April 1993 to March 2002 and chairman until his retirement in December 2002. Following IBM, Mr. Gerstner joined The Carlyle Group, a global private equity firm located in Washington, D.C.

  4. 9 de dic. de 2002 · Louis V. Gerstner, Jr. In his talk on November 20, titled "IBM's Transformation," he made clear that he did not see himself as the white knight in IBM's subsequent transition and return to viability. He had the advantage of being an outsider when he joined the company after working at McKinsey & Co., American Express Company, and RJR Nabisco.

  5. Louis V. Gerstner, Jr. IBM. 19932002. Industry: Computers & Electronics. Era: 1990. Under pressure to break-up IBM, Gerstner instead went against the tide of expectation and kept IBM in one piece. He went on to make IBM more competitive by announcing downsizing and a new vision for the company called network computing/e-business.

  6. The Louis V. Gerstner, Jr. Center for Learning is the ultimate executive retreat and professional development destination for business training, team building, or corporate events that define modern functionality, technology, and beauty, conveniently located near New York City.

  7. 26 de jun. de 2024 · Our Chairman, Louis V. Gerstner, Jr., namesake of the Gerstner Sloan Kettering Graduate School, had the opportunity to honor the graduates. This year, 10 students earned their doctoral degrees in cancer biology from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK).